MORGAN STANLEY PLC/CALL/SANOFI/134/0.1/20.12.24 Share Price

Warrant

DE000ME5YNJ2

Delayed Börse Stuttgart 19:07:42 25/06/2024 BST
0.022 EUR +10.00% Intraday chart for MORGAN STANLEY PLC/CALL/SANOFI/134/0.1/20.12.24
Current month+46.67%
1 month+22.22%
Date Price Change
25/06/24 0.022 +10.00%
24/06/24 0.02 +11.11%
21/06/24 0.018 0.00%
20/06/24 0.018 +5.88%
19/06/24 0.017 -15.00%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 07:07 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
Issuer Morgan Stanley
WKN ME5YNJ
ISINDE000ME5YNJ2
Date issued 28/12/2023
Strike 134
Maturity 20/12/2024 (178 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.119
Lowest since issue 0.009
Spread 0.013
Spread %32.50%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.87 EUR
Average target price
108.2 EUR
Spread / Average Target
+19.06%
Consensus